KDM6A and infiltrating bladder urothelial carcinoma: They reported that the proportion of KDM6A mutations in non‐muscle‐invasive urothelial bladder carcinoma was 45%, muscle‐invasive tumors was 28%, and in tumors of unknown stages was 28%.